BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28991928)

  • 41. Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome.
    Zanotti L; Bignotti E; Calza S; Bandiera E; Ruggeri G; Galli C; Tognon G; Ragnoli M; Romani C; Tassi RA; Caimi L; Odicino FE; Sartori E; Pecorelli S; Ravaggi A
    Clin Chem Lab Med; 2012 Dec; 50(12):2189-98. PubMed ID: 23096757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.
    Pietrowski D; Szabo L; Sator M; Just A; Egarter C
    Hum Reprod; 2012 Jan; 27(1):196-9. PubMed ID: 22016416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of VEGF and its receptors in endometrioid endometrial cancer.
    Dobrzycka B; Terlikowski SJ; Kwiatkowski M; Garbowicz M; Kinalski M; Chyczewski L
    Ginekol Pol; 2010 Jun; 81(6):422-5. PubMed ID: 20695190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is VEGF a marker of severity of scrub typhus infection?
    Mani VE; Chauhan PS; Kalita J; Bhoi SK; Misra UK
    Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):305-10. PubMed ID: 26718940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.
    Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM
    Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
    Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C
    Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in primary and recurrent WHO grade III meningiomas.
    Baumgarten P; Brokinkel B; Zinke J; Zachskorn C; Ebel H; Albert FK; Stummer W; Plate KH; Harter PN; Hasselblatt M; Mittelbronn M
    Histol Histopathol; 2013 Sep; 28(9):1157-66. PubMed ID: 23475388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular endothelial growth factor receptor 1 expression in nasal polyp tissue.
    Bobic S; Hox V; Callebaut I; Vinckier S; Jonckx B; Stassen JM; Jorissen M; Gevaert P; Carmeliet P; Bachert C; Ceuppens JL; Hellings PW
    Allergy; 2014 Feb; 69(2):237-45. PubMed ID: 24127643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. VEGF and its receptors (flt-1 and KDR/flk-1) as prognostic indicators in endometrial carcinoma.
    Talvensaari-Mattila A; Soini Y; Santala M
    Tumour Biol; 2005; 26(2):81-7. PubMed ID: 15867479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of serum VEGF and its soluble receptor sVEGFR1 with serum cell-free DNA in patients with breast tumor.
    El Tarhouny S; Seefeld M; Fan AX; Hahn S; Holzgreve W; Zhong XY
    Cytokine; 2008 Oct; 44(1):65-9. PubMed ID: 18691902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma levels of VEGF-A, VEGF B, and VEGFR-1 and applicability of these parameters as tumor markers in diagnosis of breast cancer.
    Zajkowska M; Lubowicka E; Malinowski P; Szmitkowski M; Ławicki S
    Acta Biochim Pol; 2018 Dec; 65(4):621-628. PubMed ID: 30543720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab.
    Smerdel MP; Steffensen KD; Waldstrøm M; Brandslund I; Jakobsen A
    Gynecol Oncol; 2010 Aug; 118(2):167-71. PubMed ID: 20471067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
    Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
    Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VEGF-A and PDGF-BB--angiogenic factors and the stage of diabetic foot syndrome advancement.
    Drela E; Kulwas A; Jundziłł W; Góralczyk B; Boinska J; Drewniak W; Gadomska G; Rość D
    Endokrynol Pol; 2014; 65(4):306-12. PubMed ID: 25185854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
    Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
    Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.
    Nakamura K; Hongo A; Kodama J; Hiramatsu Y
    Gynecol Oncol; 2011 Oct; 123(1):82-7. PubMed ID: 21764107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minimally invasive colon resection for malignant colonic conditions is associated with a transient early increase in plasma sVEGFR1 and a decrease in sVEGFR2 levels after surgery.
    Shantha Kumara HM; Cabot JC; Hoffman A; Luchtefeld M; Kalady MF; Hyman N; Feingold D; Baxter R; Whelan RL
    Surg Endosc; 2010 Feb; 24(2):283-9. PubMed ID: 19551437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value].
    Tan XJ; Lang JH; Shen K; Wang L; Wu M; Xu XY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):9-12. PubMed ID: 18366924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study.
    Zeng X; Zhang Z; Gao QQ; Wang YY; Yu XZ; Zhou B; Xi MR
    Dis Markers; 2016; 2016():9262919. PubMed ID: 27340318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.